Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system.
暂无分享,去创建一个
S. Hamasaki | I. Maruyama | S. Abe | Y. Atsuchi | S. Hamasaki | S. Arima | T. Yamashita | H. Okino | M. Tahara | S. Nakao | K. Nomoto | H. Yamaguchi | Ikuro Maruyama | Satoshi Abe | Hiroshi Yamaguchi | Minoru Tahara | Hiromitsu Tanaka
[1] R. Wilensky,et al. Urinary fibrinopeptide A levels in ischemic heart disease. , 1989, Journal of the American College of Cardiology.
[2] C. Soria,et al. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. , 1988, Thrombosis research.
[3] T. Aoyama,et al. Platelet aggregation and thromboxane B2 release in patients with acute myocardial infarction--their relation to coronary patency. , 1988, Japanese circulation journal.
[4] C. Francis,et al. INCREASED PLASMA CONCENTRATION OF CROSSLINKED FIBRIN POLYMERS IN ACUTE MYOCARDIAL INFARCTION , 1987, Thrombosis and Haemostasis.
[5] J. Soria,et al. Dynamic coronary fibrinolysis evaluation in patients with myocardial infarction and unstable angina by specific plasma fibrin degradation product determination. , 1987, Thrombosis research.
[6] M. Blombäck,et al. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.
[7] A. Gallino,et al. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia. , 1985, Circulation.
[8] M. Gent,et al. Platelet Tests and Antiplatelet Drugs in Coronary Artery Disease , 1983, Circulation.
[9] C. Prowse,et al. The in vivo release of human platelet factor 4 by heparin. , 1982, Thrombosis research.
[10] J. Lindenfeld,et al. Increased Plasma Concentrations of Platelet Factor 4 in Coronary Artery Disease: A Measure of In Vivo Platelet Activation and Secretion , 1981, Circulation.
[11] E. Frenkel,et al. Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo. , 1981, The American journal of cardiology.
[12] M S Golden,et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.
[13] D. Pepper,et al. The release, distribution, and clearance of human beta-thromboglobulin and platelet factor 4. , 1978, Thrombosis research.
[14] M. Sekiguchi,et al. Coronary thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section. , 1978, British heart journal.
[15] T. Lawrie,et al. Disordered "fibrinolytic potential" in coronary heart disease. , 1977, Thrombosis research.
[16] I. Maruyama,et al. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction]. , 1990, Journal of cardiology.
[17] T. Tsukasato. Decreased antithrombogenic activity of endothelium in patients with cerebral thrombosis. , 1988 .
[18] R. Bertina,et al. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction. , 1984, American heart journal.
[19] C. Bastl,et al. Effect of heparin on the in vivo release and clearance of human platelet factor 4. , 1983, Blood.